Gilead Sciences | Capitalização De Mercado



Market Capitalization Alterar Data
AbbVie USD 370.64B 56.62B 2025-03
Alnylam Pharmaceuticals USD 35.13B 4.7B 2025-03
Amgen USD 139.96B 33.39B 2024-12
BioMarin Pharmaceutical USD 12.54B 855M 2024-12
Bristol-Myers Squibb USD 124.1B 9.39B 2025-03
Gilead Sciences USD 139.68B 24.59B 2025-03
GlaxoSmithKline GBP 60.35B 4.54B 2025-03
Glaxosmithkline USD 69.83B 14.22B 2024-12
Incyte USD 11.72B 1.59B 2025-03
J&J USD 399.65B 51.46B 2025-03
Merck USD 225.87B 25.78B 2025-03
Neurocrine Biosciences USD 13.82B 2.18B 2024-12
Novartis CHF 194.25B 18.5B 2024-12
Pfizer USD 143.72B 6.63B 2025-03
PTC Therapeutics USD 3.51B 653M 2024-12
Sanofi EUR 125.84B 7.44B 2025-03
Sarepta Therapeutics USD 11.78B 128M 2024-12
United Therapeutics USD 13.89B 1.86B 2025-03
Vertex Pharmaceuticals USD 103.45B 16.4B 2024-12



Gilead Sciences Capitalização De Mercado - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.